Member Info for Bebeto

"on the grounds that data from the 109 COPD patients with confirmed viral infection generates useful safety, biomarker and potentially efficacy data to support ongoing trials of SNG001 in COVID-19 patients"

Confirmed viral infection is link between COPD & Covid-19. SNG-001 has to work on COPD , be safe and give a positive immune system response.

" an unplanned interim analysis on the grounds that data from the 109 COPD patients with confirmed viral infection generates useful safety, biomarker and potentially efficacy data to support ongoing trials of SNG001 in COVID-19 patients. "

From experience that's about 3wks so anytime from 16th June for results.

Yes, we would all like to see the shareprice a lot higher, the Jamaica license ends at the end of July and UOG are looking to make an approach for an extension with possibly upto 100% ownership, if they pull that rabbit out I'd expect to see the shareprice reflect it.

I don't see this as a short term play, the results/ revenues & assets will move the shareprice north. The BOD are looking at transforming their asset portfolio. I have expectations of UOG becoming mid-tier company.

GGP are actually growing gold at Havieron.

I know someone who was offered a place on a covid-19 trial in Southampton, they were paying upto £3K each but she turned it down because she didn't want to be "injected" so there's more than one trial going on there.

The target timeline for the mining lease key approval process is 65 days. If you know when they want to start mining you could backward work the application timeline. The MRE or equivalent would be needed to complete the application.

June 8th RNS : "Series of agreements to facilitate Mining Lease application at Havieron"

MRE is closer than I thought.

Will be interesting to see if Newcrest mentions how much cash they have in the bank, last time it was $1.4bn , it might not be enough if they decide to go on a summer spending spree.

We need comprehensive results and SNG have thrown everything including the kitchen sink into these results.

They must be confident of a decent pay off.

Lost track, isn't Newcrest due to release more drill results tonight?

Picture becoming a little clearer with the TR-1 , onwards and upwards now with a missing-Link .

This is my long, I feel this has real potential for 30p+ in time.

Also BL was talking about buying another asset, later this year and using our own generated cash reserves to pay for it. Speaks volumes to where this company is going.

Nolupus, from 26th May RNS :

"We have also been pleased with the progress of the SG016 trial in the hospital environment, having dosed 98 of 100 patients, and look forward to announcing top line data in July.'

This was the first indication of a delay, afterwards the shareprice broke support and has continued to fall ever since.

The BOD have already gone all in here, they've spent all they can on these trials.

The drop in shareprice is now mainly due to delays with the results, which should have been now.

It's true a high percentage of private investors do lose money, think about it, if you trade the same way as everyone else why would your results be any different.? Make a strategy that works for you and stick with it, you'll make far more money that way.

Also there was a delay in the results timeline from June to July/Summer, shareprice's naturally drift downwards with delays & uncertainties with timelines. The shareprice has now dropped significantly since delays were announced, so it's a clear buy signal for me.

AIM shares are not for the faint hearted but patience brings its own rewards. The shareprice is guaranteed to rise into the results timeline, investors strategies should account for this.

There's 149M shares in issue but the shareprice movements confirm free float is clearly well under 100M. Positive results the shareprice will go parabolic.

My buy this morning was also printed as a sell.

There's been nothing that's materially changed with the trial to effect the shareprice.

Looking forward to seeing the results.